An ageing population is often accompanied by an increase in age‑related disorders such as Parkinson’s disease, an incurable ...

Dawe, PhD, as Scientific Advisor, Neuropharmacology & Translational Neuroscience, and Tomi K. Sawyer, PhD, as Strategic ...

Marks First In-Human Clinical Study Demonstrating the Value of Immuno-Pharmacodynamics in the Assessment of Radioligand Therapy -- Novigenix AI Liquid Biopsy Platform Identifies Immune Activation ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, developed a technology based on quantum key distribution protocol and quantum random number ...

Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...

Bioness Medical, Inc. ("Bioness", or the "Company"), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies, today announced the acquisition of the PoNS® ...

Detailed price information for Cue Biopharma Inc (CUE-Q) from The Globe and Mail including charting and trades.

Broadcast Electronics, under new ownership, will introduce an AM transmitter called AMX, highlighting a compact design and ...

Fluoride-doped perovskite nanocrystal glass achieves record blue quantum yield and powers single-laser multicolor holographic ...

Willem Mulder, PhD Dr. Mulder is one of the scientific founders of Trained Therapeutix Discovery and serves as its Chief Scientific Officer, leading the company’s scientific strategy and development ...

Parkinson’s disease (PD) is entering a pivotal phase. For decades, treatment has centred on dopamine replacement to manage ...

As a synthetic decapeptide structurally derived from gonadotropin-releasing hormone (GnRH), Triptorelin has long attracted research interest due to its unusually paradoxical signalling profile.